Amoena USA Corporation

Kennesaw, Georgia

Classification

Private

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

About

About

Amoena USA Corporation is a medical products company and subsidiary of the global Amoena Group, which was founded in 1975 by Cornelius Rechenberg. Rechenberg, a plastics engineering student, developed the world's first silicone breast form as a superior alternative to the fabric and rubber bra fillers available at the time. The United States subsidiary was established in Atlanta, Georgia, in 1978 and currently maintains its headquarters in Kennesaw, Georgia. Throughout its history, the company has undergone significant corporate changes, including a 1994 merger with the Breast Care Division of Coloplast A/S DK and later acquisitions by Granville Baird Capital Partners in 2007 and Halder in 2014. Business/Product Breakdown Amoena USA Corporation specializes in the design, manufacture, and distribution of breast care solutions, focusing on products that restore body symmetry and support the healing process for women who have undergone breast surgery. The company's core product line includes various generations of silicone breast forms, ranging from weighted prostheses to lightweight options and the Contact self-adhesive breast form that adheres directly to the skin. Its "Amoena Solution" framework extends beyond prosthetics to offer comprehensive recovery care, including post-surgical compression bras, scar therapy textiles, and silicone patches designed to stabilize surgical areas and improve scar texture. In addition to medical devices, the company produces a wide range of specialized apparel featuring integrated pockets to securely hold breast forms or partial shapers. This apparel line encompasses pocketed lingerie, swimwear, and leisure wear tailored to accommodate the physical changes resulting from mastectomies, lumpectomies, or breast reconstructions. The company also incorporates proprietary technologies into its products, such as Comfort+ temperature-equalizing material to reduce perspiration and Adapt Air technology, which utilizes an integrated air chamber for adjustable volume and a personalized fit.

Keywords

Keywords

Classified

Private